5,694
Participants
Start Date
July 1, 2025
Primary Completion Date
December 31, 2029
Study Completion Date
December 31, 2029
PPG/ECG dual mode based smartwatch
The intervention initiates anticoagulation when AF is detected as either a single episode ≥1 hour or cumulative ≥2 hours/24h (adjusted for monitoring compliance), triggering a 30-day NOAC therapy cycle that restarts if AF recurs during treatment. Participants are required to wear the device ≥12 hours daily, supported by automated reminders (vibration/SMS/phone alerts) and a reward system to reinforce adherence.
Continuous DOAC therapy
Continuous standard-dose DOAC therapy with dose adjustments per the drug labels.
RECRUITING
Beijing Anzhen Hospital, Beijing
NOT_YET_RECRUITING
Shengjing Hospital Affiliated to China Medical University, Shenyang
NOT_YET_RECRUITING
First Affiliated Hospital of Dalian Medical University, Dalian
NOT_YET_RECRUITING
The First Hospital of Jilin University, Changchun
NOT_YET_RECRUITING
The First Affiliated Hospital of Harbin Medical University, Harbin
NOT_YET_RECRUITING
The First Affiliated Hospital of Nanjing Medical University, Nanjing
NOT_YET_RECRUITING
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
NOT_YET_RECRUITING
The First Affiliated Hospital of Anhui Medical University, Hefei
NOT_YET_RECRUITING
Qilu Hospital of Shandong University, Jinan
NOT_YET_RECRUITING
Liaocheng People's Hospital, Liaocheng
NOT_YET_RECRUITING
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou
NOT_YET_RECRUITING
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
NOT_YET_RECRUITING
Henan Provincial Chest Hospital, Zhengzhou
NOT_YET_RECRUITING
Luohe Central Hospital, Luohe
NOT_YET_RECRUITING
Chengdu Fifth People's Hospital, Chengdu
NOT_YET_RECRUITING
The Second Hospital of Hebei Medical University, Shijiazhuang
Beijing Anzhen Hospital
OTHER